A detailed history of Sfe Investment Counsel transactions in Danaher Corp stock. As of the latest transaction made, Sfe Investment Counsel holds 16,870 shares of DHR stock, worth $3.97 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares
16,870
Previous 15,970 5.64%
Holding current value
$3.97 Million
Previous $3.99 Million 17.52%
% of portfolio
1.01%
Previous 0.91%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$239.25 - $280.76 $215,325 - $252,684
900 Added 5.64%
16,870 $4.69 Million
Q2 2024

Aug 05, 2024

BUY
$235.51 - $267.98 $314,405 - $357,753
1,335 Added 9.12%
15,970 $3.99 Million
Q1 2024

May 03, 2024

BUY
$224.58 - $256.19 $441,299 - $503,413
1,965 Added 15.51%
14,635 $3.65 Million
Q4 2023

Jan 31, 2024

BUY
$185.1 - $233.13 $678,391 - $854,421
3,665 Added 40.7%
12,670 $2.93 Million
Q3 2023

Oct 24, 2023

BUY
$233.08 - $265.59 $291,350 - $331,987
1,250 Added 16.12%
9,005 $2.23 Million
Q2 2023

Jul 24, 2023

BUY
$224.99 - $256.14 $338,609 - $385,490
1,505 Added 24.08%
7,755 $1.86 Million
Q1 2023

May 08, 2023

BUY
$239.75 - $277.0 $433,947 - $501,370
1,810 Added 40.77%
6,250 $1.58 Million
Q4 2022

Feb 09, 2023

SELL
$241.42 - $282.29 $62,769 - $73,395
-260 Reduced 5.53%
4,440 $1.18 Million
Q3 2022

Nov 14, 2022

BUY
$247.06 - $1507.4 $40,764 - $248,721
165 Added 3.64%
4,700 $1.21 Million
Q2 2022

Aug 10, 2022

BUY
$237.11 - $299.66 $145,822 - $184,290
615 Added 15.69%
4,535 $1.15 Million
Q1 2022

May 06, 2022

BUY
$257.27 - $315.76 $460,513 - $565,210
1,790 Added 84.04%
3,920 $1.15 Million
Q4 2021

Feb 07, 2022

BUY
$292.08 - $329.01 $410,372 - $462,259
1,405 Added 193.79%
2,130 $701,000
Q3 2021

Nov 12, 2021

BUY
$272.21 - $332.43 $197,352 - $241,011
725 New
725 $221,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $171B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Sfe Investment Counsel Portfolio

Follow Sfe Investment Counsel and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sfe Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Sfe Investment Counsel with notifications on news.